Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy

Podobne zapisy

• Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy
  od: Shepherd, Frances A., i wsp.
  Wydane: (2017)
• A Pooled Exploratory Analysis of the Effect of Tumor Size and KRAS Mutations on Survival Benefit from Adjuvant Platinum-Based Chemotherapy in Node Negative Non-Small Cell Lung Cancer
  od: Cuffe, Sinead, i wsp.
  Wydane: (2012)
• Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer
  od: Brambilla, Elisabeth, i wsp.
  Wydane: (2016)
• Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection
  od: Tsao, Ming-Sound, i wsp.
  Wydane: (2015)
• Tumor Mutation Burden as a Biomarker in Resected Non–Small-Cell Lung Cancer
  od: Devarakonda, Siddhartha, i wsp.
  Wydane: (2018)